European Pharmaceutical Review

JANUARY 25, 2024

7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 Eurostat (2022) “How many citizens had basic digital skills in 2021?” percent as EU average with some Member States as high as 25 percent).

Packaging 98

Packaging Documentation Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

FEBRUARY 3, 2023

Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus. Uniquely, a group of eight independent companies and users of robotic workcells, aggregated their data from 2018- 2021, to assess the performance of innovative aseptic filling technology and help drive modern regulatory standards. 1] BioNews. Hemophilia News Today.

Communication 97

Communication Packaging Dosage Vaccines 97

IDStewardship

NOVEMBER 29, 2023

In 2021 I enrolled in a Master’s for Microbiology and cell science at the University of Florida and I am expecting to complete it in December of 2024. Not being afraid to communicate with people has been important to my success. I think that is where I do my best work I. I have found a lot of my guests through social media.

Patient Care 246

Patient Care Hospitals Packaging Communication 246

Viseven

JUNE 12, 2023

Surprisingly, nearly half of all clinical trials conducted in the world in 2021 had locations in APAC. Suyoung went to the conference to share her insights on how pharma companies can switch from traditional communication to personalized customer journeys and increase brand awareness using solutions by Viseven.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 52

PQA

JUNE 27, 2024

The measure concept continued through PQA’s multistakeholder, consensus-based development process, and the Specialty Pharmacy Turnaround Time [Pharmacy] (SP-TAT-PH) pharmacy quality measure was endorsed through a PQA membership vote in 2021. Meeting patients where they are” can help to improve communications and ultimately reduce TAT.

Specialty Pharmacies 40

Specialty Pharmacies Communication Packaging Documentation 40

European Pharmaceutical Review

JUNE 24, 2022

Following initial consultations in 2021, we expect the publication of the proposal for changes to the EU’s pharmaceutical legislation and potential adoption by the European Commission (EC) by December 2022. It is too early to say because we have not seen the whole package of measures yet. London: Dolon Ltd; 2021. References.

Compounding 105

Compounding Packaging Dosage Communication 105

Viseven

SEPTEMBER 14, 2023

It also bears extra replacement expenses when drugs are discarded due to improper packaging. One of the most common use cases is Internet of Things (IoT) sensors placed on containers and packaging to track humidity and temperature in real-time. This made the procurement process more expensive, time-consuming, and ridden with errors.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

ISPE

MARCH 8, 2023

The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

The Checkup by Singlecare

JULY 10, 2024

You’ve probably eaten seaweed as part of your favorite sushi dish before or even snacked on a package of dried seaweed from the shelf of your local health food store. Costa says a 2021 study suggests that zinc might support hormone levels and sexual function in postmenopausal women.

Immunization 85

Immunization Compounding Packaging Communication 85

The FDA Law Blog

NOVEMBER 2, 2023

The absence of standards was a focal point of the Cellular, Tissue and Gene Therapies Advisory Committee Meeting in September 2021 that was convened to discuss the toxicity risks of AAV vector-based gene therapy products.

FDA 59

FDA Packaging Documentation Labelling 59

ISPE

JANUARY 10, 2023

The strategy is to provide an appropriate characterization package that demonstrates the alternative filter or resin will not impact product quality, submit it in a PAS, and, if needed, submit a request for an expedited review. 5 (2021): 60–62. Published 3 September 2021. Recorded 25 August 2021. Updated May 2021.

Packaging 52

Packaging FDA Communication Vaccines 52

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). 1 (2021):48. 6540 (2021):341–42. Nature Communications 12, no.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MAY 9, 2023

In addition to the COR, some Latin American markets require approval in the COO, which is defined as the country where the drug is manufactured, packaged, or exported from. Sometimes, COAs for the drug substance, the excipients used in the formulation, and the primary and nonfunctional secondary packaging material are requested.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MARCH 7, 2023

As such there’s a growing question of how the industry will improve the sustainability profile of its existing medicines and ensure that sustainability is designed into new medicines, such as products, with a reduced environmental risk, greener manufacturing technologies, and recyclable delivery systems and packaging. 9 December 2021.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

ISPE

MARCH 29, 2023

Published 15 November 2021. Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

Published 15 November 2021. Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 15, 2023

4 The biopharmaceutical industry is taking steps to increase its environmental sustainability, 5 which begins with identifying and testing alternatives to existing procurement, materials, logistics, equipment, services, manufacturing processes, packaging, and facility design 6 (see Table 1). 14–25 (November–December 2021). HowToRobot.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

ISPE

OCTOBER 27, 2022

16 (20 September 2021): 9026–41. As a result, some companies have challenged the paradigm by forgoing lyophilization entirely, opting to provide solution phase API to drug product facilities for filling and packaging. You may unsubscribe from these ISPE communications at any time. Pharmaceutics 14, no. 2 (February 2022): 260.

Process Improvement 98

Process Improvement Packaging Compounding Dosage 98

ISPE

MARCH 6, 2023

Sixth Assessment Report: Climate Change 2021: The Physical Science Basis.” Finalized 9 August 2021. Yet if we consider these 74 companies to be representative of the entire biotechnology and pharmaceutical industry, the carbon intensity has increased by over 40% since 2015, with a marked increase over the last 2 years (2020 and 2021).

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

OCTOBER 27, 2022

Published 17 May 2021. 53 (2021): doi:10.1038/s41392-021-00487-6. Different engineering disciplines, such as architectural and process piping, may use different software packages, which can then be combined into a single coordinated model. Published 21 September 2021. Accessed 11 August 2021. Viral Vector Modality.

Packaging 52

Packaging Communication Immunization Vaccines 52

ISPE

MARCH 7, 2023

10 May 2021. Representatives from R&D, manufacturing and supply, and commercial should all be included at the top-level forum, along with the main functions needed for delivery such as the sustainability group, engineering, procurement, legal, and corporate communications. October 2021. Gerber, and K. April 2016. March 2004.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

AUGUST 29, 2022

For changes requiring approval before implementation, once the necessary information has been submitted across regions, each health authority must review the data package and documentation based on local requirements. Journal of Pharmaceutical Sciences (2021). Common Technical Document [CTD] sections). Sugrue-Richards, and G.

Documentation 52

Documentation FDA Communication Packaging 52

The Thyroid Pharmacist

OCTOBER 27, 2023

Follow package instructions. These signals create communication and function within nerves and muscles, as the electrolytes move in or out of cells. Follow package directions for each supplement. The herb itself can be poisonous if ingested. They’re great for injuries, overuse, or soreness from workouts.

Health and Personal Care Stores 96

Health and Personal Care Stores Immunization Compounding Packaging 96

ISPE

AUGUST 30, 2022

In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP). Finally, the DP is packaged in a suitable container to ensure continued quality. 5 (September/October 2021). 2021.09.046 2021. Published 2008. Guidance for Industry.

Documentation 52

Documentation FDA Packaging Communication 52

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

SEPTEMBER 10, 2023

In these countries, a secondary packaging site change or an active pharmaceutical ingredient (API) manufacturing site addition triggers a new submission equivalent to that required for approval of a generic drug or a line extension, whereas these site changes may be filed as a notification in the US and EU. Published 2021. Edwards, K.

Documentation 98

Documentation Process Improvement Packaging Pharmaceutical Companies 98

Pharmaceutical Technology

MARCH 21, 2023

Based on the individual contract, these CMOs manufacture small molecules or biological active pharmaceutical ingredients (APIs), as well as packaging material, and are charged with other related functions. Sharp Packaging Services is producing the solid dose of the drug and packaging it.

Packaging 59

Packaging FDA Vaccines Labelling 59

Pharmaceutical Technology

DECEMBER 8, 2022

Forward-thinking suppliers, including packaging component providers, are also looking at how they can improve their processes through digital technologies. Tom Lenaerts is head of global process engineering for Datwyler, a leading supplier of parenteral packaging components such as stoppers and plungers. Free Whitepaper. By Datwyler.

Packaging 98

Packaging Vaccines Communication 98

Pharmaceutical Technology

MARCH 22, 2023

The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. The question is whether rising inflation levels and major global events will allow for development and innovation.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

JANUARY 20, 2023

In a 2021 GlobalData poll 3 , environmental issues were viewed as the most important area that pharma needs to address, according to 43% of respondents. While using high-capacity aircraft and minimal packaging reduces weight and increases capacity for vital products by using fewer flights.

Pharmaceutical Companies 142

Pharmaceutical Companies Pharmaceutical Companies Packaging Communication 142

Pharmaceutical Technology

DECEMBER 15, 2022

Kenilworth, NJ, US) is investing $500 million in its Singapore facilities, including setting up a secondary packaging facility and building an inhaler production plant. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Additionally, Merck & Co. Free Report.

Vaccines 105

Vaccines Packaging Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

APRIL 21, 2023

Nevertheless, Narcan represents a life-saving treatment option that is free of prescription barriers and will be key in managing a drug epidemic that resulted in the deaths of more than 106,000 people in America in 2021. “We 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Packaging 52

Packaging Communication FDA 52

Pharmaceutical Technology

MARCH 7, 2023

Due to rising healthcare spending, launch of novel treatments, and the rise of chronic diseases in an aging population, the global pharmaceutical packaging equipment market is rapidly expanding. billion in 2021, which is expected to reach $15.77 Recent analysis valued the market [i] at USD 8.5

Dosage 52

Dosage Packaging Communication 52

Pharmaceutical Technology

JANUARY 15, 2023

While Catalent Inc and PCI Pharma Services are in charge of the solid dose and packaging of Lupkynis, Lonza is manufacturing the small molecule API. Vetter Pharma-Fertigung GmbH & Co KG is conducting the parenteral manufacture and packaging for Trulicity. Catalent Inc has been tasked with the solid dose manufacturing for the drug.

Labelling 52

Labelling Packaging FDA Communication 52

Pharmaceutical Technology

JUNE 20, 2023

It plans to work with the FDA to plan new analyses and further develop a new application package. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Data presented was drawn from the first 100 patients enrolled in F2G’s Phase IIb, single-arm, open-label trial (NCT03583164).

FDA 52

FDA Packaging Labelling Communication 52

Pharmaceutical Technology

NOVEMBER 30, 2022

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. The evolution of CCIT. Please check your email to download the Webinar.

Packaging 52

Packaging FDA Communication 52

Pharmaceutical Technology

FEBRUARY 3, 2023

In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. Compared to other dosage forms, tablets are simpler to manufacture, package, and transport. As with any pharmaceutical manufacturing, challenges can be many, and processes are highly regulated.

Packaging 52

Packaging Dosage Pharmaceutical Companies Pharmaceutical Companies 52